COVID-19 Therapeutic Drug Development

Various research strategies are being deployed to control the COVID-19 pandemic, including a search for a vaccine. This feed covers primarily the ongoing research efforts that are focused on repurposing existing antiviral drugs and finding novel therapeutic treatments.

January 19, 2021
Review
Open Access

Review of pharmacologic and immunologic agents in the management of COVID-19

Biosafety and Health
Marzuq A UngogoGarba M Khalid
January 17, 2021

An EUA for baricitinib (Olumiant) for COVID-19

The Medical Letter on Drugs and Therapeutics
January 19, 2021
Review
Open Access

COVID-19 discharge and follow-up recommendations

Proceedings
Mahmoud AbdelnabiJ Drew Payne
January 17, 2021

SARS-CoV-2-associated multisystem inflammatory syndrome in children: clinical manifestations and the role of infliximab treatment

European Journal of Pediatrics
Nahed Abdel-HaqJocelyn Y Ang
January 19, 2021

The Role of Nutrition during the COVID-19 Pandemic: What We Know

Endocrine, Metabolic & Immune Disorders Drug Targets
Elsa VitaleThea Magrone
January 16, 2021
Case Report
Open Access

Complement Inhibition in Severe COVID-19 Acute Respiratory Distress Syndrome

Frontiers in Pediatrics
Sharmila RaghunandanSatheesh Chonat
January 20, 2021
Open Access

Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2

PLoS Pathogens
Tianling OuMichael Farzan
January 20, 2021

Mucor in a Viral Land: A Tale of Two Pathogens

Indian Journal of Ophthalmology
Mrittika SenSantosh G Honavar
January 16, 2021
Review
Open Access

Cancer in corona times

Saudi Journal of Anaesthesia
Shagun Bhatia Shah, Rajiv Chawla
January 19, 2021

Identification of 1,2,3-triazole-phthalimide derivatives as potential drugs against COVID-19: a virtual screening, docking and molecular dynamic study

Journal of Biomolecular Structure & Dynamics
Vanderlan Nogueira HolandaRegina Celia Bressan Queiroz de Figueiredo
January 17, 2021

Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection

Proceedings of the National Academy of Sciences of the United States of America
Jia-Tsrong JanChi-Huey Wong
January 16, 2021
Case Report
Open Access

COVID-19 in Liver Transplant Recipients - A Series with Successful Recovery

Journal of Clinical and Translational Hepatology
Ashok ChoudhuryShiv Kumar Sarin
January 17, 2021
Open Access

Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs

Trials
Florence RodgersVictoria Pilkington
January 20, 2021

The Role of Justicia Adhatoda as prophylaxis for COVID-19 - Analysis based on docking study

Infectious Disorders Drug Targets
Pugazhenthan ThangarajuEswaran Thangaraju
January 19, 2021
Open Access

Protease inhibitor GC376 for COVID-19: Lessons learned from feline infectious peritonitis

Annals of Medicine and Surgery
Khan SharunKuldeep Dhama
January 17, 2021

COVID-19 after kidney transplantation: Early outcome and renal function following antiviral treatment

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Alina Daciana ElecFlorin Ioan Elec

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Cardiovascular Complications

Growing evidence shows that COVID-19 can result in serious complications affecting the cardiovascular system, including dysrhythmias, myocarditis, acute myocardial infarction, and heart failure. This feed follows studies investigating the effects of SARS-CoV-2 infection on the heart.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

© 2021 Meta ULC. All rights reserved
/feed-previews/covid-19-therapeutic-drug-development/e729c905-a7db-497d-864f-8620b6604159